Shiga Toxin 1 (Stx-1) 抗体
Cited in 2+ publications. This anti-Shiga Toxin 1 antibody is a 小鼠 单克隆 antibody detecting Shiga Toxin 1 in WB, IA 和 InhA. Suitable for Shigella dysenteriae.
(2 references)
产品编号 ABIN2192153
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Shiga Toxin 1 (Stx-1) 抗体 (ABIN2192153)
抗原
Shiga Toxin 1 (Stx-1)
适用
Shigella dysenteriae
宿主
小鼠
克隆类型
单克隆
标记
非结合性
应用范围
Western Blotting (WB), Immunoassay (IA), Inhibition Assay (InhA)
克隆位点
13C4
-
-
过滤
- 0.2 μm filtered
-
-
-
-
应用备注
- For Western blotting dilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:10. For inhibition of biological activity in vitro dilutions have to be made according to the amounts of toxin to be inactivated.
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS, containing 0.1 % bovine serum albumin.
-
储存条件
- 4 °C
-
储存方法
- Product should be stored at 4 °C. Under recommended storage conditions, product is stable for one year.
-
有效期
- 12 months
-
-
-
: "Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2." in: Vaccine, Vol. 24, Issue 19, pp. 4122-9, (2006) (PubMed).
: "Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli." in: Infection and immunity, Vol. 50, Issue 3, pp. 695-700, (1986) (PubMed).
-
: "Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2." in: Vaccine, Vol. 24, Issue 19, pp. 4122-9, (2006) (PubMed).
-
- Shiga Toxin 1 (Stx-1)
-
背景
- The monoclonal antibody 13C4 recognizes the 1B subunit of Shiga-like toxin 1. Shiga-like toxins (SLTs), are also called Verotoxins. Enterohemorrhagic Escherichia coli (EHEC) strains which are primarily of serotypes 0157:H7, 026:H11 and O111:H8 have been incriminated as etiologic agents of hemorrhagic colitis and Hemolytic-uremic syndrome, a generalized disease characterized by acute renal failure, thrombocytopenia, and microangiopathic hemolytic anemia. There are several distinct E.coli SLTs. SLT-I and SLT-II are produced by EHEC. SLT-I and Shiga toxin share >99 % deduced amino acid sequence homology, whereas SLT-I and SLT-II share about 60 % deduced amino acid sequence homology. SLT-I and SLT-II are antigenically distinct. The protein structure of the toxin consists of two domains: the A polypeptide that inhibits protein synthesis by targeting ribosomes, and the B polypeptide pentamer that binds to the eukaryotic cell receptor globotriaosylceramide (Gb3) leading to receptor-mediated endocytosis.
抗原
-
You are here:
